Biological Action of Epidermal Growth Factor and Its Functional Receptors in Normal Mammary Epithelial Cells

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1983 May 1

PMID 6302699

Citations 16

Authors

Y Taketani

T Oka

Affiliations

Soon will be listed here.

Abstract

Normal murine mammary epithelial cells possessed the capacity to bind epidermal growth factor (EGF) in a specific and saturable manner. Scatchard plot analysis showed a curvilinear pattern. Assuming that this is not due to negative cooperativity of EGF binding, the data suggest the presence of two classes of receptors with a high and a low affinity: Kd values = 1 x 10(-10)M and 3.6 x 10(-9)M, respectively. The number of high- and low-affinity receptors was estimated to be 800 per cell and 8,600 per cell, respectively. The occupancy of EGF receptors for a half-maximal stimulation of DNA synthesis or inhibition of casein synthesis was about 10% and 6% of total receptors, respectively. A potent tumor promoter, 12-O-tetradecanoylphorbol 13-acetate, acted synergistically with EGF in terms of stimulation of DNA synthesis but not in terms of inhibition of casein synthesis when the two agents were added at a suboptimal concentration. The presence of the tumor promoter increased the amount of EGF bound to mammary cells in culture and also decreased a loss in the amount of EGF in the culture medium. These results indicate that mammary epithelial cells possess functional receptors for EGF, which are modulated by the tumor promoter.

Citing Articles

Counting growth factors in single cells with infrared quantum dots to measure discrete stimulation distributions.

Le P, Lim S, Baculis B, Chung H, Kilian K, Smith A Nat Commun. 2019; 10(1):909.

PMID: 30796217 PMC: 6385258. DOI: 10.1038/s41467-019-08754-5.

Brk/PTK6 sustains activated EGFR signaling through inhibiting EGFR degradation and transactivating EGFR.

Li X, Lu Y, Liang K, Hsu J, Albarracin C, Mills G Oncogene. 2012; 31(40):4372-83.

PMID: 22231447 PMC: 3326223. DOI: 10.1038/onc.2011.608.

EGF receptor signaling blocks aryl hydrocarbon receptor-mediated transcription and cell differentiation in human epidermal keratinocytes.

Sutter C, Yin H, Li Y, Mammen J, Bodreddigari S, Stevens G Proc Natl Acad Sci U S A. 2009; 106(11):4266-71.

PMID: 19255421 PMC: 2649958. DOI: 10.1073/pnas.0900874106.

DiAugustine R, Richards R, Sebastian J J Mammary Gland Biol Neoplasia. 1997; 2(2):109-17.

PMID: 10882297 DOI: 10.1023/a:1026395513038.

Prolactin inhibits epidermal growth factor (EGF)-stimulated signaling events in mouse mammary epithelial cells by altering EGF receptor function.

Fenton S, Sheffield L Mol Biol Cell. 1993; 4(8):773-80.

PMID: 8241565 PMC: 300991. DOI: 10.1091/mbc.4.8.773.

References

Aharonov A, Pruss R, Herschman H . Epidermal growth factor. Relationship between receptor regulation and mitogenesis in 3T3 cells. J Biol Chem. 1978; 253(11):3970-7. View

Gorden P, Carpentier J, Cohen S, Orci L . Epidermal growth factor: morphological demonstration of binding, internalization, and lysosomal association in human fibroblasts. Proc Natl Acad Sci U S A. 1978; 75(10):5025-9. PMC: 336255. DOI: 10.1073/pnas.75.10.5025. View

Taketani Y, Oka T . Tumor promoter 12-O-tetradecanoylphorbol 13-acetate, like epidermal growth factor, stimulates cell proliferation and inhibits differentiation of mouse mammary epithelial cells in culture. Proc Natl Acad Sci U S A. 1983; 80(6):1646-9. PMC: 393659. DOI: 10.1073/pnas.80.6.1646. View

Lee L, Weinstein I . Epidermal growth factor, like phorbol esters, induces plasminogen activator in HeLa cells. Nature. 1978; 274(5672):696-7. DOI: 10.1038/274696a0. View

Lee L, Weinstein I . Mechanism of tumor promoter inhibition of cellular binding of epidermal growth factor. Proc Natl Acad Sci U S A. 1979; 76(10):5168-72. PMC: 413101. DOI: 10.1073/pnas.76.10.5168. View

Ono M, Oka T . The differential actions of cortisol on the accumulation of alpha-lactalbumin and casein in midpregnant mouse mammary gland in culture. Cell. 1980; 19(2):473-80. DOI: 10.1016/0092-8674(80)90522-x. View

Shechter Y, Hernaez L, Cuatrecasas P . Epidermal growth factor: biological activity requires persistent occupation of high-affinity cell surface receptors. Proc Natl Acad Sci U S A. 1978; 75(12):5788-91. PMC: 393060. DOI: 10.1073/pnas.75.12.5788. View

Haigler H, McKanna J, Cohen S . Direct visualization of the binding and internalization of a ferritin conjugate of epidermal growth factor in human carcinoma cells A-431. J Cell Biol. 1979; 81(2):382-95. PMC: 2110321. DOI: 10.1083/jcb.81.2.382. View

Taketani Y, Oka T . Possible physiological role of epidermal growth factor in the development of the mouse mammary gland during pregnancy. FEBS Lett. 1983; 152(2):256-60. DOI: 10.1016/0014-5793(83)80391-3. View

10.

Ances I . Serum concentrations of epidermal growth factor in human pregnancy. Am J Obstet Gynecol. 1973; 115(3):357-62. DOI: 10.1016/0002-9378(73)90591-7. View

11.

Hunter W, GREENWOOD F . Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature. 1962; 194:495-6. DOI: 10.1038/194495a0. View

12.

Takigawa M, Verma A, Simsiman R, Boutwell R . Polyamine biosynthesis and skin tumor promotion: inhibition of 12-O-tetradecanoylphorbol-13-acetate-promoted mouse skin tumor formation by the irreversible inhibitor of ornithine decarboxylase alpha-difluoromethylornithine. Biochem Biophys Res Commun. 1982; 105(3):969-76. DOI: 10.1016/0006-291x(82)91065-8. View

13.

Rosenthal H . A graphic method for the determination and presentation of binding parameters in a complex system. Anal Biochem. 1967; 20(3):525-32. DOI: 10.1016/0003-2697(67)90297-7. View

14.

Tonelli Q, SOROF S . Epidermal growth factor requirement for development of cultured mammary gland. Nature. 1980; 285(5762):250-2. DOI: 10.1038/285250a0. View

15.

Rees A, Adamson E, Graham C . Epidermal growth factor receptors increase during the differentiation of embryonal carcinoma cells. Nature. 1979; 281(5729):309-11. DOI: 10.1038/281309a0. View

16.

Baker J, Cunningham D . Glucocorticoid-mediated alteration in growth factor binding and action: analysis of the binding change. J Supramol Struct. 1978; 9(1):69-77. DOI: 10.1002/jss.400090108. View

17.

Yang J, Guzman R, Richards J, Imagawa W, McCormick K, Nandi S . Growth factor- and cyclic nucleotide-induced proliferation of normal and malignant mammary epithelial cells in primary culture. Endocrinology. 1980; 107(1):35-41. DOI: 10.1210/endo-107-1-35. View

18.

Cohen S, Savage Jr C . Recent studies on the chemistry and biology of epidermal growth factor. Recent Prog Horm Res. 1974; 30(0):551-74. DOI: 10.1016/b978-0-12-571130-2.50018-3. View

19.

Shoyab M, De Larco J, Todaro G . Biologically active phorbol esters specifically alter affinity of epidermal growth factor membrane receptors. Nature. 1979; 279(5712):387-91. DOI: 10.1038/279387a0. View